Zweig-DiMenna Associates’s ASML ASML Stock Holding History

Zweig-DiMenna Associates’s Portfolio ASML Stock Details ASML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,623	Closed	-$1.82M	–	70
2024 Q4	$1.82M	Sell	2,623 -5,250	-67%	-$3.77M	0.14%	80
2024 Q3	$6.56M	Sell	7,873 -7,750	-50%	-$6.93M	0.66%	48
2024 Q2	$16M	Hold	15,623	–	–	1.8%	18
2024 Q1	$15.2M	Buy	+15,623	New	+$13.9M	1.32%	19
2023 Q2	–	Sell	-4,850	Closed	-$3.3M	–	117
2023 Q1	$3.3M	Buy	+4,850	New	+$3.11M	0.45%	70
2019 Q4	–	Sell	-39,415	Closed	-$9.79M	–	90
2019 Q3	$9.79M	Sell	39,415 -22,916	-37%	-$5.16M	0.87%	45
2019 Q2	$13M	Buy	62,331 +32,766	+111%	+$6.51M	1.23%	34
2019 Q1	$5.56M	Buy	+29,565	New	+$5.23M	0.62%	56
2018 Q1	–	Sell	-68,316	Closed	-$11.9M	–	141
2017 Q4	$11.9M	Buy	+68,316	New	+$12.1M	1.29%	27
2016 Q2	–	Sell	-137,500	Closed	-$13.8M	–	149
2016 Q1	$13.8M	Buy	+137,500	New	+$12.4M	1.22%	29

Other funds holding ASML

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Zweig-DiMenna Associates's ASML Position: Q1 2025 in Review

Zweig-DiMenna Associates sold out of ASML (ASML) in Q1 2025, closing a stake of 2,623 shares — an estimated $1.82M sold.

Zweig-DiMenna Associates first reported a position in ASML in Q1 2016 and held it in 10 quarters. The position peaked at $16M in Q2 2024. 1,622 funds tracked by Wall St. Rank hold ASML as of Q1 2025.

Zweig-DiMenna Associates reported no remaining ASML position as of Q1 2025 after selling out during the quarter.
Zweig-DiMenna Associates sold 2,623 ASML shares in Q1 2025, an estimated $1.82M.
Zweig-DiMenna Associates first reported a position in ASML in Q1 2016 and held it in 10 quarters.
Zweig-DiMenna Associates's ASML position peaked at $16M in Q2 2024.
1,622 funds tracked by Wall St. Rank held ASML as of Q1 2025.

Based on Zweig-DiMenna Associates's 13F filing for Q1 2025, filed 7 May 2025.